Inuvo Inc
F:CD5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inuvo Inc
F:CD5
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
XMUN:CUP
|
JP |
|
C
|
Chugai Pharmaceutical Co Ltd
F:CUP
|
JP |
|
A
|
Arrail Group Ltd
F:I1D
|
CN |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
Wall St Price Targets
CD5 Price Targets Summary
Inuvo Inc
According to Wall Street analysts, the average 1-year price target for CD5 is 3.398 EUR with a low forecast of 2.039 EUR and a high forecast of 5.088 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CD5's stock price target?
Price Target
3.398
EUR
According to Wall Street analysts, the average 1-year price target for CD5 is 3.398 EUR with a low forecast of 2.039 EUR and a high forecast of 5.088 EUR.
What is the Revenue forecast for Inuvo Inc?
Projected CAGR
-22%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is -22%.
What is the Gross Profit forecast for Inuvo Inc?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is -7%.
